Dr Marta Di Forti is a Clinical Reader in Psychosis Research at the Dept of Social, Developmental and Genetic Research, Institute of Psychiatry, and Honorary Consultant Adult Psychiatrist, Lambeth EI Community team, South London and Maudsley NHS foundation Trust. She leads the first Cannabis Clinic for patients with Psychotic disorders in UK. She was recently awarded the Royal College of Psychiatrist Researcher of the year prize. In 2020 she was granted a MRC Senior Research Fellowship to expand her research in the role of cannabis use in psychosis and its underlying biology. With her team she showed for the first time that use of high potency types of cannabis e.g. "skunk" carries a higher risk of psychosis than use of traditional types and that it affects rates of Psychotic disorders across Europe. Though it still remains unclear who are those cannabis use most at risk. Her future work aims to investigate the interaction between cannabis use and genes predisposing to schizophrenia, and how cannabis changes the epigenome.
Lancet Article: Daily High Potency (10%) Cannabis Use is associated with nearly 5 fold increased odds of Psychotic Disorder
Drug testing became a standard after a landmark even in 1981 when a marine warfare jet slammed into the USS Nimitz’s flight deck. Autopsies...
Can Marijuana cause Murder? In a landmark case, Bryn Spejcher was convicted of involuntary manslaughter after stabbing her boyfriend Chad O'Meila 108 times. Heidi...
Dr. Karl Hill directs the Prevention Science Program and is a professor of Psychology and Neuroscience at the University of Colorado Boulder, and is...